Procter & Gamble Hygiene and Health Care Limited (PGHH.NS)
INR 14104.0
(3.05%)
INR 14104.0
(3.05%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 8.13 Billion INR | -4.84% |
| 2022 | 14.31 Billion INR | 15.86% |
| 2021 | 12.35 Billion INR | -10.69% |
| 2020 | 13.83 Billion INR | 22.97% |
| 2019 | 11.25 Billion INR | 16.12% |
| 2018 | 9.69 Billion INR | 23.68% |
| 2017 | 7.83 Billion INR | 16.5% |
| 2016 | 6.72 Billion INR | -22.65% |
| 2015 | 8.69 Billion INR | 3.39% |
| 2014 | 8.4 Billion INR | 15.68% |
| 2013 | 7.26 Billion INR | 10.58% |
| 2012 | 6.57 Billion INR | 19.51% |
| 2011 | 5.5 Billion INR | 37.74% |
| 2010 | 3.99 Billion INR | 8.13% |
| 2009 | 3.69 Billion INR | 31.5% |
| 2008 | 2.8 Billion INR | 191.86% |
| 2007 | -3.05 Billion INR | -242.42% |
| 2006 | 2.14 Billion INR | 20.55% |
| 2005 | 1.78 Billion INR | -6.24% |
| 2004 | 1.89 Billion INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 4.32 Billion INR | 101.59% |
| 2023 FY | 13.62 Billion INR | -4.84% |
| 2023 Q1 | 4.19 Billion INR | 44.87% |
| 2023 Q3 | 3.47 Billion INR | -9.75% |
| 2023 Q4 | 3.52 Billion INR | 1.71% |
| 2023 Q2 | 3.84 Billion INR | -8.32% |
| 2022 Q1 | 4.07 Billion INR | 293.88% |
| 2022 FY | 14.31 Billion INR | 15.86% |
| 2022 Q4 | 2.89 Billion INR | -20.19% |
| 2022 Q3 | 3.62 Billion INR | -2.52% |
| 2022 Q2 | 3.72 Billion INR | -8.7% |
| 2021 Q2 | 4.29 Billion INR | 3.28% |
| 2021 Q4 | 1.03 Billion INR | -64.54% |
| 2021 FY | 12.35 Billion INR | -10.69% |
| 2021 Q3 | 2.91 Billion INR | -31.98% |
| 2021 Q1 | 4.15 Billion INR | 45.23% |
| 2020 Q2 | 3.75 Billion INR | 10.41% |
| 2020 Q3 | 3.82 Billion INR | 2.03% |
| 2020 Q4 | 2.86 Billion INR | -25.26% |
| 2020 Q1 | 3.39 Billion INR | 214.49% |
| 2020 FY | 13.83 Billion INR | 22.97% |
| 2019 FY | 11.25 Billion INR | 16.12% |
| 2019 Q1 | 3.43 Billion INR | 141.22% |
| 2019 Q2 | 3.62 Billion INR | 5.53% |
| 2019 Q3 | 3.1 Billion INR | -14.45% |
| 2019 Q4 | 1.08 Billion INR | -65.2% |
| 2018 Q4 | 1.42 Billion INR | -47.61% |
| 2018 FY | 9.69 Billion INR | 23.68% |
| 2018 Q3 | 2.72 Billion INR | -1.17% |
| 2018 Q2 | 2.75 Billion INR | -1.37% |
| 2018 Q1 | 2.79 Billion INR | 4.51% |
| 2017 Q4 | 2.67 Billion INR | 15.43% |
| 2017 FY | 7.83 Billion INR | 16.5% |
| 2017 Q3 | 2.31 Billion INR | 2.01% |
| 2017 Q2 | 2.26 Billion INR | 10.23% |
| 2017 Q1 | 2.05 Billion INR | 3.82% |
| 2016 FY | 6.72 Billion INR | -22.65% |
| 2016 Q3 | 1.96 Billion INR | 1.39% |
| 2016 Q2 | 1.94 Billion INR | -8.08% |
| 2016 Q1 | 2.11 Billion INR | 7.34% |
| 2016 Q4 | 1.98 Billion INR | 0.75% |
| 2015 Q2 | 2.07 Billion INR | -18.69% |
| 2015 FY | 8.69 Billion INR | 3.39% |
| 2015 Q4 | 1.96 Billion INR | -15.05% |
| 2015 Q3 | 2.31 Billion INR | 11.52% |
| 2015 Q1 | 2.55 Billion INR | 33.22% |
| 2014 Q1 | 2.4 Billion INR | 85.11% |
| 2014 Q4 | 1.91 Billion INR | -1.48% |
| 2014 Q2 | 2.41 Billion INR | 0.35% |
| 2014 FY | 8.4 Billion INR | 15.68% |
| 2014 Q3 | 1.94 Billion INR | -19.43% |
| 2013 FY | 7.26 Billion INR | 10.58% |
| 2013 Q4 | 1.29 Billion INR | -23.57% |
| 2013 Q3 | 1.7 Billion INR | -27.49% |
| 2013 Q2 | 2.34 Billion INR | 21.8% |
| 2013 Q1 | 1.92 Billion INR | 39.91% |
| 2012 Q1 | 1.48 Billion INR | -1.29% |
| 2012 FY | 6.57 Billion INR | 19.51% |
| 2012 Q3 | 1.61 Billion INR | -20.74% |
| 2012 Q2 | 2.03 Billion INR | 36.63% |
| 2012 Q4 | 1.37 Billion INR | -14.59% |
| 2011 Q1 | 1.27 Billion INR | 64.67% |
| 2011 Q2 | 1.39 Billion INR | 8.88% |
| 2011 Q3 | 1.27 Billion INR | -8.17% |
| 2011 Q4 | 1.5 Billion INR | 18.04% |
| 2011 FY | 5.5 Billion INR | 37.74% |
| 2010 FY | 3.99 Billion INR | 8.13% |
| 2010 Q4 | 775.5 Million INR | -22.25% |
| 2010 Q3 | 997.4 Million INR | 0.0% |
| 2009 FY | 3.69 Billion INR | 31.5% |
| 2008 FY | 2.8 Billion INR | 191.86% |
| 2007 FY | -3.05 Billion INR | -242.42% |
| 2006 FY | 2.14 Billion INR | 20.55% |
| 2005 FY | 1.78 Billion INR | -6.24% |
| 2004 FY | 1.89 Billion INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Ambica Agarbathies Aroma & Industries Limited | 196.31 Million INR | -4044.39% |
| Bajaj Consumer Care Limited | 3.9 Billion INR | -108.411% |
| BCL Industries Limited | 407.57 Million INR | -1896.202% |
| Colgate-Palmolive (India) Limited | 36.87 Billion INR | 77.938% |
| Cupid Limited | 176 Million INR | -4522.784% |
| Dabur India Limited | 21.91 Billion INR | 62.869% |
| Emami Limited | 10.72 Billion INR | 24.13% |
| Gillette India Limited | 5.5 Billion INR | -47.851% |
| Godrej Consumer Products Limited | 34.56 Billion INR | 76.459% |
| Hindustan Unilever Limited | 96.12 Billion INR | 91.535% |
| Honasa Consumer Limited | 8.36 Billion INR | 2.765% |
| JHS Svendgaard Laboratories Limited | 183.68 Million INR | -4329.376% |
| Jyothy Labs Limited | 5.72 Billion INR | -42.048% |
| Kaya Limited | 1.3 Billion INR | -525.13% |
| Marico Limited | 21.36 Billion INR | 61.91% |
| N.K Industries Limited | 201.82 Million INR | -3931.185% |
| S H Kelkar and Company Limited | 2.69 Billion INR | -202.334% |